Minireviews
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Jun 26, 2021; 13(6): 170-176
Published online Jun 26, 2021. doi: 10.4330/wjc.v13.i6.170
Cardiogenic shock in the setting of acute myocardial infarction: Another area of sex disparity?
Syed Bukhari, Shumail Fatima, Islam Y Elgendy
Syed Bukhari, Shumail Fatima, Cardiovascular Medicine, University of Pittsburgh, Pittsburgh, PA 15261, United States
Islam Y Elgendy, Department of Medicine, Weill Cornell Medicine-Qatar, Doha 24144, Qatar
Author contributions: Bukhari S, Fatima S designed, performed the collection of the data, edited, and wrote the paper; Elgendy IY contributed to the critical revision and editing of the paper.
Conflict-of-interest statement: The authors have no conflicts of interest to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Islam Y Elgendy, FACC, FACP, FAHA, MD, Assistant Professor, Consultant Physician-Scientist, Department of Medicine, Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, Doha 24144, Qatar. iyelgendy@gmail.com
Received: March 11, 2021
Peer-review started: March 11, 2021
First decision: March 31, 2021
Revised: April 3, 2021
Accepted: May 21, 2021
Article in press: May 21, 2021
Published online: June 26, 2021
Core Tip

Core Tip: Sex disparities exist among different cardiovascular diseases and therapies. Cardiogenic shock is a leading cause of death among patients with acute myocardial infarction. Although some studies suggest that cardiogenic shock is more prevalent among women, women are less likely to receive guideline-recommended management including revascularization, which might explain why are more likely to experience worse outcomes.